Toshihiro Wajima
- Pharmacology top 2%
- Infectious Diseases top 5%
- Epidemiology top 10%
- Molecular Medicine top 1%
- Virology top 2%
- Co-authors
- Takayuki KatsubeRoger EcholsTôru IshibashiYoshitaka YanoTakayoshi OgumaKazuya FukumuraStephen C. PiscitelliNao Kawaguchi
- Topics
- Antibiotics Pharmacokinetics and Efficacy (24 papers)Pneumonia and Respiratory Infections (14 papers)Antibiotic Resistance in Bacteria (13 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Toshihiro Wajima
57 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 88
- Pharmacology 440
- Infectious Diseases 430
- Epidemiology 424
- Molecular Medicine 358
- Virology 248
Countries citing papers authored by Toshihiro Wajima
This map shows the geographic impact of Toshihiro Wajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiro Wajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiro Wajima more than expected).
Fields of papers citing papers by Toshihiro Wajima
This network shows the impact of papers produced by Toshihiro Wajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiro Wajima. The network helps show where Toshihiro Wajima may publish in the future.
Co-authorship network of co-authors of Toshihiro Wajima
This figure shows the co-authorship network connecting the top 25 collaborators of Toshihiro Wajima. A scholar is included among the top collaborators of Toshihiro Wajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihiro Wajima. Toshihiro Wajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 21 | |
| 3 | 61 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 9 | |
| 7 | 9 | |
| 8 | 4 | |
| 9 | 3 | |
| 10 | 14 | |
| 11 | 23 | |
| 12 | 22 | |
| 13 | 19 | |
| 14 | 30 | |
| 15 | 2 | |
| 16 | 48 | |
| 17 | 12 | |
| 18 | 55 | |
| 19 | 9 | |
| 20 | 58 |
About Toshihiro Wajima
Toshihiro Wajima is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (24 papers), Pneumonia and Respiratory Infections (14 papers) and Antibiotic Resistance in Bacteria (13 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (147 citations), Molecular Medicine (358 citations) and Virology (248 citations). Toshihiro Wajima has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Takayuki Katsube, Roger Echols, Tôru Ishibashi, Yoshitaka Yano, Takayoshi Oguma, Kazuya Fukumura, Stephen C. Piscitelli, Nao Kawaguchi, Julie Borland and Ivy Song. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.